Back

vaccinogen,-inc

Vaccinogen, Inc. 5300 Westview Drive, Suite 406, Frederick, MD 21703, USA Attn: Andrew L. Tussing Tel: 301-668-8400 Email: info@vaccinogeninc.com www.vaccinogeninc.com

Description

Vaccinogen, Inc. is a US based biotechnology company with more than three decades of research
into combating cancer by using the body’s own immune system. Vaccinogen is the developer of
OncoVAX®, is the only patient specific immunotherapy for Stage II colon cancer, an unmet medical
need, that embraces the validated evidence that carcinomas are heterogeneous and cannot be
treated by homogeneous modalities. Vaccinogen’s cGMP manufacturing facility is licensed and
operational in Emmen, The Netherlands, which is capable of manufacturing up to 3,000 vaccines per
year. Vaccinogen’s technology may also have application in other tumor types, notably melanoma,
ovarian and renal cell carcinoma.
Vaccinogen is a biotechnology company with more than three decades of research into
combating cancer by using the body’s own immune system. It is the producer of OncoVAX®,
an immunotherapy for Stage II colon cancer.